Schedule a meeting
Market opportunity

Everyone serves the 12% — we serve the 88%

Arcus Medical targets the vast underserved population of women seeking minimally invasive pelvic organ prolapse care — those avoiding surgery due to cost, recovery time, and stigma.

Competitive landscape

Where everyone else competes — and where we're differentiated

12%

Traditional market — surgical

  • FDA ban on transvaginal mesh eliminated a primary treatment option.
  • Abdominal mesh only — mainly via robotic sacrocolpopexy.
  • Hospital-based, requiring specialized OR infrastructure.
  • Complex native-tissue reconstruction demanding advanced surgical expertise.
88%

Arcus TLT market — non-surgical

  • Vaginal pessaries — high discontinuation, uncomfortable.
  • Pelvic-floor therapies — Kegels, biofeedback, EM stimulation; high failure for moderate-to-severe POP.
  • Untreated patients living with symptoms due to limited options.
  • Arcus addresses the gap with a simple, office-based approach.

A differentiated position in non-surgical care

The 12% surgical segment is well served today. Arcus is focused on the large underserved population seeking alternatives to traditional surgery.

88%

Underserved segment

The population seeking non-surgical options.

Office

Office-based approach

Designed for in-office and ASC use.

$900M

Estimated opportunity

Based on internal analyses and published prevalence estimates.

Current market limitations

3,000 years of limited progress in treating POP

Vaginal pessaries

The oldest documented treatment, yet still widely used today.

  • Uncomfortable and require frequent maintenance
  • Low patient compliance and satisfaction
  • Outdated — doesn't address the root cause
  • Many women simply give up on treatment

Traditional surgery

Invasive procedures with significant barriers.

  • Requires a hospital setting and general anesthesia
  • High cost and extended recovery time
  • FDA removal of transvaginal mesh created a vacuum
  • Only 12% of affected women choose this option
The market need

A simple, office-based, minimally invasive approach

Exactly what Arcus TLT provides. Let's review the opportunity together.

Schedule a meeting Explore the technology